Metraipolis › archive › dc_7e3d87f57a9a
Hybrid Nanocarriers for Cancer Therapy: Advancements in Co-Delivery of Gene Therapy and Immunotherapy — Europe PMC PMID:41516128
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41516128
- DOI
- 10.3390/ijms27010248
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T10:10:43.262Z
- SHA-256 of the archived text
4746fb79e9110871b911786333245549027540851e3a73c928011563e1ab257d- Stable URL of this page
https://metraipolis.com/documento/dc_7e3d87f57a9a
How to cite
Hybrid Nanocarriers for Cancer Therapy: Advancements in Co-Delivery of Gene Therapy and Immunotherapy — Europe PMC PMID:41516128 — Europe PMC (en), https://europepmc.org/article/MED/41516128 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e3d87f57a9a (Metraipolis archive dc_7e3d87f57a9a, sha256 4746fb79e9110871b911786333245549027540851e3a73c928011563e1ab257d)
BibTeX
@misc{dc7e3d87f57a9a,
title = {Hybrid Nanocarriers for Cancer Therapy: Advancements in Co-Delivery of Gene Therapy and Immunotherapy — Europe PMC PMID:41516128},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41516128},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e3d87f57a9a; sha256 4746fb79e9110871b911786333245549027540851e3a73c928011563e1ab257d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41516128. Agents can read the archived copy with the MCP tool read_document.